Volume 95 Issue 20 | p. 21 | Concentrates
Issue Date: May 15, 2017

U.S. slams China, India, and others over weak patent protection

By Glenn Hess, special to C&EN
Department: Government & Policy
Keywords: intellectual property, patents, counterfeit drugs, trade

The Trump Administration is sharply criticizing India, China, Indonesia, and several other countries it says are not properly enforcing and protecting the intellectual property rights of U.S. drugmakers and other businesses. In a congressionally required annual report released in late April, the Office of the U.S. Trade Representative (USTR) placed 11 countries on a “priority watch list” for their perceived intellectual property rights abuses, such as failing to prevent the export of . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society